Bridgeway Capital Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-30,000
Closed -$454K 1390
2019
Q3
$454K Hold
30,000
0.01% 991
2019
Q2
$567K Buy
30,000
+12,400
+70% +$211K 0.01% 938
2019
Q1
$308K Buy
17,600
+6,500
+59% +$119K ﹤0.01% 1147
2018
Q4
$193K Buy
+11,100
New +$166K ﹤0.01% 1224
2016
Q3
Sell
-258,000
Closed -$581K 1480
2016
Q2
$581K Buy
+258,000
New +$743K 0.01% 979

Other funds holding VCEL

Bridgeway Capital Management's VCEL Position: Q4 2019 in Review

Bridgeway Capital Management sold out of Vericel Corp (VCEL) in Q4 2019, closing a stake of 30,000 shares — an estimated $454K sold.

Bridgeway Capital Management first reported a position in VCEL in Q2 2016 and held it in 5 quarters. The position peaked at $581K in Q2 2016. 148 funds tracked by Wall St. Rank hold VCEL as of Q4 2019.

  • Bridgeway Capital Management reported no remaining Vericel Corp position as of Q4 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 30,000 Vericel Corp shares in Q4 2019, an estimated $454K.
  • Bridgeway Capital Management first reported a position in Vericel Corp in Q2 2016 and held it in 5 quarters.
  • Bridgeway Capital Management's Vericel Corp position peaked at $581K in Q2 2016.
  • 148 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2019.

Based on Bridgeway Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.